Results 231 to 240 of about 606,113 (264)
Some of the next articles are maybe not open access.

Related searches:

RNA interference and its application in bone-related diseases

Biochemical and Biophysical Research Communications, 2007
RNA interference (RNAi) is the most exciting insight in biology in past decades, which provided new perspectives into the genome-wide surveys of gene function by targeted degradation of mRNA with the introduction of small interfering RNAs (siRNAs) or small hairpin RNAs (shRNAs) in a large variety of organisms, and turned out to be a more efficient and ...
Ya Lin, Li   +3 more
openaire   +2 more sources

Nanoscale materials-based platforms for the treatment of bone-related diseases

Matter, 2021
Summary Owing to the high density of bone tissue and the complex and highly hierarchical structure, drugs used for the treatment of bone-related diseases are often not effectively concentrated at the site of the lesion. Generally, the therapeutic effect is unsatisfactory, and the long-term use of drugs causes adverse effects.
Xiaodi Zhang   +10 more
openaire   +1 more source

The role of the fibroblast growth factor family in bone‐related diseases

Chemical Biology & Drug Design, 2019
AbstractFibroblast growth factor (FGF) family members are important regulators of cell growth, proliferation, differentiation, and regeneration. The abnormal expression of certain FGF family members can cause skeletal diseases, including achondroplasia, craniosynostosis syndrome, osteoarthritis, and Kashin–Beck disease. Accumulating evidence shows that
Jicheng Wang   +3 more
openaire   +2 more sources

Recent advances in functional nanostructured materials for bone-related diseases

Journal of Materials Chemistry B, 2019
This article reviews the recent advances in the development of nanostructured materials for bone-related diseases such as osteoporosis and osteoarthritis.
Anqi Li, Jing Xie, Jianshu Li
openaire   +2 more sources

[Research progress of necroptosis on bone related diseases].

Zhongguo gu shang = China journal of orthopaedics and traumatology, 2021
As a new type of cell death, necroptosis is initiated by tumor necrosis factor receptor 1(TNFR1), and then activated receptor-interacting protein kinase 1(RIP1) and receptor-interacting protein kinase 3 (RIP3), following by the activation of mixed lineage kinase domain-like protein(MLKL) to deliver cell death signal.
Zu-Ge, Yang   +5 more
openaire   +1 more source

The role of Notch signaling pathway in metabolic bone diseases

Biochemical Pharmacology, 2023
Yongguang Gao
exaly  

Home - About - Disclaimer - Privacy